Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethicon Inc.

Division of Johnson & Johnson
www.ethiconinc.com

Latest From Ethicon Inc.

UK Innovation, EU Regulation And Digital Transformation Are Top Themes For Medtechs At NHS Expo 2018

NHS England chief Simon Stevens has a habit of stealing headlines in UK health-care circles, and his CAR-T cell therapy approval announcement did the trick at the NHS 2018 Innovation Expo. But medtech innovation schemes and furthering the UK digital agenda emerged as main talking points at the meeting.

Market Access United Kingdom

Boston Scientific Wins Pelvic Mesh Bellwether

A Massachusetts jury has ruled that Boston Scientific is not at fault for adverse events experienced by a woman implanted with the company’s pelvic mesh products. This is the third time that juries in the state have ruled in favor of the company in an ongoing series of suits.

Legal Issues Safety

Puerto Rico Tax-Haven Status, R&D Credit Weakened By Tax-Reform Bill

Under tax reform legislation recently passed by Congress, a 20% tax on products made in domestic territories will adversely affect the many device firms with Puerto Rican plants that currently enjoy a lower, 4% tax rate on profits. And a second tax provision usually relied upon by medtech companies, the R&D tax credit, also loses ground under the final Senate bill passed Dec. 2.

Legislation Policy & Regulation

Medtronic Stands To Be Biggest Beneficiary Of J&J's Exit From Insulin Pump Market

Animas, a division of Johnson & Johnson, will stop making Animas Vibe and OneTouch Ping insulin pumps, close operations, and exit the insulin pump business, the company announced Oct. 5. J&J is offering patients currently using these devices the option to transfer to Medtronic device. Medtronic is already the leading supplier of insulin pumps worldwide.

Diabetic Care Companies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register